AZO GANTRISIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Azo Gantrisin, and what generic alternatives are available?
Azo Gantrisin is a drug marketed by Roche and is included in one NDA.
The generic ingredient in AZO GANTRISIN is phenazopyridine hydrochloride; sulfisoxazole. There are eight drug master file entries for this compound. Additional details are available on the phenazopyridine hydrochloride; sulfisoxazole profile page.
Summary for AZO GANTRISIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Patent Applications: | 3,172 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | AZO GANTRISIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AZO GANTRISIN
US Patents and Regulatory Information for AZO GANTRISIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | AZO GANTRISIN | phenazopyridine hydrochloride; sulfisoxazole | TABLET;ORAL | 019358-001 | Aug 31, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
